GLP-1R

 A

TL;DR: GLP-1 Receptor Agonists (Ozempic, Wegovy, Zepbound) and Muscle Loss

Topic	Key Takeaway
Main Concern	People worry that GLP-1 drugs cause excessive muscle loss during weight reduction.
Peter's Overall View	The concern is real but often overstated. The key question is not simply how much lean mass is lost, but whether actual muscle function and strength are preserved.
Lean Mass ≠ Muscle Mass	DEXA scans measure "lean mass," which includes water, glycogen, organs, connective tissue, and muscle—not muscle alone.
Why Lean Mass Falls	Weight loss reduces glycogen and water stores, causing DEXA-measured lean mass to decline even when muscle tissue is relatively preserved.
Strength Matters More	Muscle strength, mobility, and physical function are often more meaningful outcomes than DEXA-derived lean mass measurements.
Can Function Improve?	Yes. Many patients become stronger and move better after losing substantial excess weight, despite some lean mass reduction.
Semaglutide (Ozempic/Wegovy)	Associated with lean mass loss, but much of it occurs alongside substantial fat loss.
Tirzepatide (Zepbound/Mounjaro)	Appears to preserve lean mass somewhat better than semaglutide in available studies.
Were Early Results Alarming?	Some early trial findings raised concerns, but later data suggest those results may have overstated the problem.
Compared with Dieting Alone	Current evidence does not clearly show that GLP-1 drugs cause substantially greater muscle loss than traditional calorie restriction producing similar weight loss.
Highest-Risk Groups	Older adults, frail individuals, sedentary people, and those consuming inadequate protein.
Bone Health Concerns	Weight loss can affect bone density, making preservation of muscle and skeletal loading important.
SELECT Trial	Provided important safety data, including examination of fracture risk, particularly hip and pelvic fractures.
Most Important Intervention	Progressive resistance training is considered essential while using GLP-1 medications.
Protein Intake	Peter emphasizes high daily protein intake and often has patients track protein rather than calories.
Why Track Protein?	Adequate protein helps preserve muscle during weight loss and supports recovery from training.
Stopping the Drug	Weight regain is common after discontinuation.
Weight Regain Data	A significant portion of lost weight often returns within the year after stopping therapy.
Lean Mass After Stopping	Regained weight typically includes both fat and lean tissue.
Future Therapies	New agents such as Retatrutide may produce greater weight loss and potentially different body-composition effects.
Gray-Market Products	Peter advises caution regarding non-regulated or gray-market versions because of quality and safety concerns.

---

Peter's Practical Formula for Preserving Muscle on GLP-1 Therapy

Priority	Importance
Resistance training	Essential
Adequate protein intake	Essential
Continued physical activity	Essential
Monitoring strength and function	More useful than focusing solely on DEXA lean mass
Avoiding excessive caloric restriction	Important
Long-term maintenance strategy	Critical after stopping medication

Bottom Line

GLP-1 medications do lead to some loss of lean mass during weight loss, but current evidence suggests much of this is expected during substantial weight reduction and does not necessarily represent excessive loss of functional muscle. The best protection is a combination of resistance training, sufficient protein intake, and ongoing physical activity.